Clinical trials
AIS clinical trials
Below are recruiting ais clinical trials, each written for real people, not researchers. We’re tracking 688 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07107022Recruiting
Study of Penumbra System for acute ischemic stroke
This study is collecting information on how well the Penumbra System works and how safe it is when used to remove blood clots in people having a certain type of stroke. It is for patients who are eligible for mechanical thrombectomy (a procedure to remove the clot) using this device as the first treatment.
Nedlands, Western AustraliaAges 18–80 - NCT07718750Recruiting
AI text messages for better sleep
This study tests if personalized text messages generated by artificial intelligence can help improve sleep. You may join if you have trouble sleeping and use a smartphone.
New York, New YorkAges 18–75 - NCT05791227Enrolling by invitation
Testing AI tool that measures heart wall thickness on ultrasound
This study tests an artificial-intelligence (AI) software tool that measures heart muscle thickness from routine heart ultrasound images. It focuses on whether the AI measurements are safe and accurate when used by the clinic’s echocardiography team.
Los Angeles, CaliforniaAges 18–100 - NCT05890716Recruiting
AI analyzes your ECG to help in high-risk heart rhythm cases
This trial uses an AI program to review ECG heart-tracing data collected from short-term monitoring devices. It aims to see whether the AI can better detect concerning heart rhythm patterns in people who are high risk for heart rhythm or heart problems.
Groningen, Provincie GroningenAges 4 years+ - NCT06859840Recruiting
Liver tumor detection AI study for cirrhosis patients
This trial tests an AI tool to find and classify liver tumors in people with cirrhosis or extrahepatic cancer who've had a non-contrast CT scan. You may join if you have cirrhosis or a cancer outside the liver, but not if you already have a malignant liver tumor or have had a liver transplant.
Hangzhou, ZhejiangAges 18–90 - NCT07702708Recruiting
AI predicts chemotherapy response in HR+/HER2- breast cancer
This trial uses AI to analyze your pre-treatment MRI and predict how well your tumor will respond to chemotherapy before surgery. It is for people with HR+/HER2- breast cancer who need chemo before their operation.
Fuzhou, FujianAges 18 years+ - NCT07703761Recruiting
AI analysis of brain tumor MRI scans
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
TrentoAges 18–60 - NCT07457840Enrolling by invitation
AI predictions for clinician decisions
This trial tests how well doctors and nurses use AI predictions to help make decisions. You'll answer a few clinical cases online.
San Francisco, CaliforniaAges 18 years+ - NCT04466059Recruiting
AI tool for leukemia diagnosis using blood or marrow samples
This study tests whether an AI (computer system) can help improve leukemia and related blood cancer diagnoses. You may be able to help if your doctor is already evaluating you for a possible blood disorder and your sample is high enough quality for testing.
Munich, BavariaAges 18 years+ - NCT05687968Recruiting
Using phone food logs to improve diabetes care
This study tests an approach to diabetes care that relies on you recording what you eat using a smartphone. It may help the research team learn how food patterns relate to blood sugar and how to improve care.
TaipeiAges 20 years+ - NCT05704491Recruiting
AI screening for diabetic eye damage
This study tests an artificial intelligence (AI) screening method to detect diabetic retinopathy, a type of eye damage caused by diabetes. It may help find eye changes earlier, so treatment can be planned sooner.
DüsseldorfAges 18 years+ - NCT05816655RecruitingPhase 2
Test two hormone treatment combinations for metastatic breast cancer
This Phase 2 study compares two combinations of hormone-blocking drugs plus an anti-cancer targeted pill to see which works better for hormone-receptor positive, HER2-negative metastatic breast cancer. It may help by finding a more effective treatment plan when the cancer has spread.
SeoulAges 19–80 - NCT05883072Recruiting
Using AI to support care for people with diabetes in Pakistan
This study tests whether AI-generated support can be helpful for adults living with diabetes. You may be asked to participate if you live in Pakistan and can legally consent.
Karachi, SindhAges 18–100 - NCT05921773Recruiting
Near-infrared brain monitoring and training for anxiety
This study tests whether using a painless light-based brain monitor and “neurofeedback” training can help track and reduce symptoms in people with generalized anxiety disorder. If you are eligible, you would receive sessions during the study and be able to communicate in Chinese.
TaipeiAges 18 years+ - NCT05987774Recruiting
AI program to help social communication for people with autism
This trial tests an AI-based program to improve social conversation skills for individuals with autism spectrum disorder. It may help if you have trouble with specific areas like empathy during conversations.
Stanford, CaliforniaAges 11–35 - NCT05988515Recruiting
AI-assisted treatment for children struggling with the 'r' sound
This study tests a computer-assisted program to help children and teens improve their 'r' sound. It is designed for those who struggle with saying 'r' and want to work on it through online sessions.
Syracuse, New YorkAges 9–17 - NCT06017843Recruiting
Using AI to find TB cases in community camps
This trial tests whether an AI tool can help find undiagnosed tuberculosis (TB) faster in community camps. If you are over 15 and visiting a camp site, you may be able to join and help improve TB detection.
IslamabadAges 15 years+ - NCT06083649Recruiting
Dental education: AI vs. human counseling for gum disease
This trial compares two ways of teaching about dental care—AI-assisted education versus speaking with a counselor—to see which one helps people with gum disease better control plaque and improve treatment outcomes.
Kaohsiung CityAges 35–65 - NCT06195202Recruiting
Estradiol levels in breast cancer patients on hormone therapy
This study measures estradiol (a female hormone) levels in breast cancer patients receiving hormone therapy. It helps doctors understand how well different treatments are working and may guide future care.
Guangzhou, GuangdongAges 18 years+ - NCT06235931Recruiting
Darcilil with AI and pyrrotinib for advanced breast cancer
This trial tests a combination of three drugs (darcilil, an aromatase inhibitor, and pyrrotinib) for older adults with a specific type of advanced breast cancer that has both HER2 and hormone receptors. It aims to see if this mix works better than current treatments.
Suzhou, JiangsuAges 65 years+ - NCT06266026Recruiting
AI-enhanced thermal imaging for breast cancer screening
This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.
HeidelbergAges 18 years+ - NCT06313983RecruitingPhase 3
Study of hemay022 plus hormone therapy for advanced breast cancer
This trial tests a new targeted drug (hemay022) combined with an aromatase inhibitor (a type of hormone therapy) for people with advanced breast cancer that is both hormone-receptor-positive and HER2-positive. It may be an option if you've already tried trastuzumab or a similar treatment and it stopped working.
BeijingAges 18 years+ - NCT06324981Recruiting
AI text messages to help your heart health
This study tests if text messages from an AI program can help you improve your heart health habits, like taking medication on time and managing blood pressure, cholesterol, or diabetes.
Denver, ColoradoAges 18–89 - NCT06363435Recruiting
AI study of tumor burden on PSMA PET-CT scans
This trial tests an AI tool that measures tumor burden on PSMA PET-CT scans. If you are having this scan for prostate cancer, it could help doctors get more detailed information from your images.
LundAges 20–120
Hear when a new AIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ais?
- Yes. Clin2 currently lists 688 recruiting ais studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ais trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ais trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.